FDA Adverse Event Injury Summary report: N

CONTAK RENEWAL

MDR report key: 2052031 · Received April 12, 2011

Report

Report Number
2124215-2011-03993
Event Type
Injury
Date Received
April 12, 2011
Date of Event
February 22, 2011
Report Date
February 22, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
NIK
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

ALL AVAILABLE INFORMATION INDICATES THAT THIS PRODUCT REMAINS IN SERVICE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) WAS HOSPITALIZED AFTER EXPERIENCING SYNCOPE. IT WAS NOTED THAT THIS PATIENT HAD A 12 SECOND PAUSE IN PACING. PATIENT ISOMETRICS AND MANIPULATIONS WERE PERFORMED, AND THE LOSS OF CAPTURE COULD NOT BE RECREATED. IT WAS FURTHER NOTED THAT WHEN THE LEFT VENTRICULAR (LV) LEAD WAS PROGRAMMED OFF, GOOD RV PACE AND CAPTURE WERE OBSERVED. THERE WAS ALSO A HISTORY OF NOISE ON THE ATRIAL AND SHOCK CHANNELS. ALL OTHER LEAD MEASUREMENTS WERE NOTED TO BE NORMAL. TECHNICAL SERVICES (TS) DISCUSSED THE POSSIBILITY OF THE TWO INSTANCES OF PREVIOUS NOISE COULD HAVE BEEN DUE TO THE MECHANICAL INTERACTION OF A TEMPORARY PACING WIRE WHILE THE PATIENT WAS HOSPITALIZED. TS ALSO DISCUSSED THAT IT WAS UNKNOWN AT THIS TIME WHAT CAUSED THE REPORTED ASYSTOLE. ADDITIONAL INFORMATION WAS RECEIVED THAT THE LV IMPEDANCES WERE GREATER THAN 2,000 OHMS. THE LV LEAD WAS SUBSEQUENTLY PROGRAMMED OFF AND THE RIGHT VENTRICULAR (RV) SENSITIVITY WAS DECREASED TO LEAST TO AVOID OVERSENSING OF ATRIAL ACTIVITY. IT WAS NOTED THAT THE LV LEAD WOULD BE REPLACED WHEN THE DEVICE REACHES ELECTIVE REPLACEMENT INDICATOR (ERI).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CONTAK RENEWAL IMPLANTABLE CHF GENERATOR NIK GUIDANT CRM CLONMEL IRELAND H210

Patients

Seq Age Sex Outcome Treatment
1 78 YR Life Threatening H210| 4543| T127| 4549| 4017| 0148| 1861